BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Prostate cancer AND CCDC6, D10S170, 8030, ENSG00000108091, Q16204, TPC, H4, TST1 AND Diagnosis
5 results:

  • 1. Human cancer Cell Radiation Response Investigated through Topological Analysis of 2D Cell Networks.
    Tirinato L; Onesto V; Garcia-Calderon D; Pagliari F; Spadea MF; Seco J; Gentile F
    Ann Biomed Eng; 2023 Aug; 51(8):1859-1871. PubMed ID: 37093401
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. prostate health index (PHI) as a reliable biomarker for prostate cancer: a systematic review and meta-analysis.
    Agnello L; Vidali M; Giglio RV; Gambino CM; Ciaccio AM; Lo Sasso B; Ciaccio M
    Clin Chem Lab Med; 2022 Jul; 60(8):1261-1277. PubMed ID: 35567430
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Distinct tumor microenvironments of lytic and blastic bone metastases in prostate cancer patients.
    Ihle CL; Provera MD; Straign DM; Smith EE; Edgerton SM; Van Bokhoven A; Lucia MS; Owens P
    J Immunother Cancer; 2019 Nov; 7(1):293. PubMed ID: 31703602
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. prostate cancer detection on dynamic contrast-enhanced MRI: computer-aided diagnosis versus single perfusion parameter maps.
    Sung YS; Kwon HJ; Park BW; Cho G; Lee CK; Cho KS; Kim JK
    AJR Am J Roentgenol; 2011 Nov; 197(5):1122-9. PubMed ID: 22021504
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. [Expression of B7-H4 in prostate cancer and its clinical significance].
    Qian Y; Yao HP; Shen L; Cheng LF; Zhang LH
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2010 Jul; 39(4):345-9. PubMed ID: 20731031
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.